FDA-2010-P-0549-0001 · 2013. 6. 3. · Lupin, and not Teva, is eligible for 180-day generic...
34
FDA-2010-P-0549-0001 · 2013. 6. 3. · Lupin, and not Teva, is eligible for 180-day generic exclusivity, pursuant to 21 U.S.C. § 355G)(5)(B)(iv), for lamivudine and zidovudine tablets,